Identifying Strategies for Robust Survivorship Program Implementation: A Qualitative Analysis of Cancer Programs.


Journal

JCO oncology practice
ISSN: 2688-1535
Titre abrégé: JCO Oncol Pract
Pays: United States
ID NLM: 101758685

Informations de publication

Date de publication:
03 2022
Historique:
pubmed: 5 10 2021
medline: 23 4 2022
entrez: 4 10 2021
Statut: ppublish

Résumé

The Commission on Cancer seeks to promote robust survivorship programs among accredited cancer programs. In practice, cancer programs' survivorship programs range from cursory (eg, developing care plans without robust services) to robust (eg, facilitating follow-up care). To inform cancer programs' future efforts, in this study, we identified the implementation strategies that cancer programs used to achieve robust survivorship programs, distinguishing them from cursory programs. We sampled 39 cancer programs across the United States with approaches to survivorship program implementation ranging from cursory to robust on the basis of LIVESTRONG survivorship care consensus elements. Within sampled cancer programs, we conducted in-depth semistructured interviews with a total of 42 health care professionals. We used template analysis to distinguish implementation strategies used in cancer programs with robust survivorship programs from strategies that yielded cursory survivorship programs. Cancer programs with robust survivorship programs established clear systems survivorship care and formal committees to improve the survivorship care processes. They sought buy-in from multiple stakeholders to leverage cancer program resources and defined clear roles with shared accountability among multidisciplinary groups. By contrast, cancer programs with cursory survivorship programs reported less consistency in survivorship care processes and lacked buy-in from key stakeholders. They had limited resources, faced persistent structural concerns, and had insufficient clarity in roles among team members. Accrediting bodies may consider incorporating the implementation strategies that robust survivorship programs have used as guidance for supporting cancer programs in operationalizing survivorship care and evaluating the use of these strategies during the accreditation and review process.

Identifiants

pubmed: 34606296
doi: 10.1200/OP.21.00357
pmc: PMC8932497
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e304-e312

Subventions

Organisme : NCI NIH HHS
ID : UG1 CA233373
Pays : United States
Organisme : NCI NIH HHS
ID : UG1 CA189823
Pays : United States
Organisme : NCI NIH HHS
ID : UG1 CA233180
Pays : United States
Organisme : NCI NIH HHS
ID : UG1 CA233184
Pays : United States
Organisme : NCI NIH HHS
ID : T32 CA116339
Pays : United States

Références

J Natl Compr Canc Netw. 2019 May 1;17(5.5):607-610
pubmed: 31117043
Support Care Cancer. 2017 Oct;25(10):3171-3179
pubmed: 28434095
J Natl Compr Canc Netw. 2020 Aug;18(8):1016-1023
pubmed: 32755975
JCO Oncol Pract. 2020 Aug;16(8):447-450
pubmed: 32267803
J Oncol Pract. 2018 Aug;14(8):e462-e483
pubmed: 30004824
Oncologist. 2013;18(4):381-90
pubmed: 23442307
CA Cancer J Clin. 2019 Sep;69(5):363-385
pubmed: 31184787
Patient Educ Couns. 2012 Sep;88(3):427-35
pubmed: 22658248
J Oncol Pract. 2015 Jan;11(1):e19-27
pubmed: 25205779
J Cancer Surviv. 2011 Sep;5(3):271-82
pubmed: 21553353
J Cancer Surviv. 2014 Jun;8(2):156-66
pubmed: 24578154
Patient Educ Couns. 2005 Jun;57(3):342-9
pubmed: 15893218
Implement Sci. 2015 Feb 12;10:21
pubmed: 25889199
J Natl Cancer Inst. 2019 Nov 1;111(11):1120-1130
pubmed: 31095326

Auteurs

Soohyun Hwang (S)

Health Policy and Management, University of North Carolina Chapel Hill, Chapel Hill, NC.

Burcu Bozkurt (B)

Health Policy and Management, University of North Carolina Chapel Hill, Chapel Hill, NC.

Tamara Huson (T)

Health Policy and Management, University of North Carolina Chapel Hill, Chapel Hill, NC.

Sarah Asad (S)

Health Policy and Management, University of North Carolina Chapel Hill, Chapel Hill, NC.

Lauren Richardson (L)

Health Policy and Management/Kenan-Flagler Business School, University of North Carolina at Chapel Hill, Chapel Hill, NC.

Joseph Amarachi Ogbansiegbe (JA)

Health Policy and Management, University of North Carolina Chapel Hill, Chapel Hill, NC.

Laura Viera (L)

University of North Carolina at Chapel Hill, Chapel Hill, NC.

Caroline Buse (C)

School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC.

Ted A James (TA)

Breast Center/Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.

Deborah K Mayer (DK)

University of North Carolina, Lineberger Comprehensive Cancer Center, Chapel Hill, NC.

Lawrence N Shulman (LN)

Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.

Sarah A Birken (SA)

Wake Forest University School of Medicine, Winston-Salem, NC.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH